[Mixed polyneuropathy as a form of presentation of serologically AACN-P positive microscopic panarteritis].
Tornero
C
C
González
A
A
del Olmo
A
A
Taberner
P
P
D000368:Aged; D001168:Arthritis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D001241:Aspirin / Q000008:administration & dosage / Q000627:therapeutic use; D001323:Autoantibodies / Q000276:immunology*; D001774:Blood Chemical Analysis; D003593:Cytoplasm / Q000276:immunology*; D003937:Diagnosis, Differential; D004576:Electromyography; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use; D009069:Movement Disorders / Q000150:complications / Q000175:diagnosis; D009504:Neutrophils / Q000276:immunology*; D014657:Vasculitis / Q000150:complications / Q000276:immunology
D001323:Autoantibodies; D001241:Aspirin; D008775:Methylprednisolone
Polineuropatía mixta como forma de presentación de la panarteritis microscópica con serología positiva AACN-P.